Determination of Product Thickness Applied on Different Areas of the Face Using a Multispectral Imaging Method
Determination of the Thickness Truly Applied of the SPRAY50+ on Different Areas of the Face Estimated by a Multispectral Imaging Method, After Application of the Product With and Without Recommendations of Use by a Group of Healthy Subjects
1 other identifier
observational
26
1 country
1
Brief Summary
The aim of the study is to determine:
- the thickness of the RV4369A truly applied on different areas of the face after single application of the product determined by a multispectral imaging method.
- the influence of a second application of the product 15 to 30 minutes after the first application on the product thickness determined by multispectral imaging method.
- the influence of the recommendations of use provided to the subjects before application of the product on the product thickness determined by multispectral imaging method .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 29, 2022
CompletedFirst Submitted
Initial submission to the registry
April 19, 2023
CompletedFirst Posted
Study publicly available on registry
May 1, 2023
CompletedMay 3, 2023
April 1, 2023
25 days
April 19, 2023
April 28, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Amounts of sun spray applied to the face, measured by multispectral imaging after single application by the subject
The product quantity applied by the subject (mg/cm2) will be extrapolated from a reference curve build using an image analysis technique
Visit 1 (Day 1)
Amounts of sun spray applied to the face, measured by multispectral imaging after 2 applications by the subject
The product quantity applied by the subject (mg/cm2) will be extrapolated from a reference curve build using an image analysis technique
Visit 1 (Day 1)
Amounts of sun spray applied to the face, measured by multispectral imaging after 1 application by the subject and according to the recommendations of use provided by the technician
The product quantity applied by the subject (mg/cm2) will be extrapolated from a reference curve build using an image analysis technique
Visit 2 (Day 10)
Comparisons between measurements of sun spray amounts determined by multispectral imaging
Comparaisons between an application without recommendations of use (Visit 1), an application without recommendations followed by a second application (Visit 1) and an application according to the recommendations of use (Visit 2)
Visit 1 (Day1) and visit 2 (Day 10)
Study Arms (1)
Treated Group
all subjects will apply the study product RV4369A
Interventions
The product is applied 1 or 2 times during the 2 study visits. The product is recovered by the technician after application of the product by the volunteer. Application modalities: Inclusion Assessment: The study product is given to the volunteer who applies it to his face (forehead) according to his usual habits. After a waiting time and Multispectral camera measurements, the study product is again applied by the volunteer to his face according to his usual habits. Final assessment: The study product is applied by the Clinical Research Technician on the subject's forearm on 4 delimited areas at specific quantities. After a waiting period and Multispectral camera measurements on the forearm areas, the study product is given to the volunteer who applies it on his face according to the recommendations of use provided by the Technician.
Eligibility Criteria
Panel of healthy volonteers
You may qualify if:
- Dry, normal to combination skin
- Phototype I to V inclusive.
- Absence of significant facial hair.
You may not qualify if:
- Population
- Pregnant, breastfeeding women.
- For men: moustached or bearded.
- Substantial hair on the forearm and face.
- With scars or other cutaneous characteristics, sunburn on forearms in the test areas, the size of which is considered incompatible with the study.
- Diseases :
- Known history of allergy to any of the investigational product ingredients.
- Known history of allergy to latex.
- Skin lesions or skin disease on the face or on the arms and forearms that may affect test results (seborrheic dermatitis, atopic dermatitis, psoriasis, acne, rosacea, etc.).
- Treatments:
- Ongoing local or Oral treatment (retinoids, anti-inflammatory) that may affect test results.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Skin Research Center
Toulouse, France
Study Officials
- PRINCIPAL INVESTIGATOR
Thérèse Nocera, MD
Pierre Fabre Dermo Cosmetique
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 19, 2023
First Posted
May 1, 2023
Study Start
April 4, 2022
Primary Completion
April 29, 2022
Study Completion
April 29, 2022
Last Updated
May 3, 2023
Record last verified: 2023-04